Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers - Wikidata - wikimedia - TriplyDB

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

http://www.wikidata.org/entity/Q28206482

about

sameAs

Targeting BRAF in thyroid cancer Polymorphisms of the BRAF gene predispose males to malignant melanoma Cancer Stem Cells in the Thyroid Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review Pax-8-PPAR-γ fusion protein in thyroid carcinoma Association of aberrant methylation of tumor suppressor genes with tumor aggressiveness and BRAF mutation in papillary thyroid cancer RASSF1A and NORE1A methylation and BRAFV600E mutations in thyroid tumors RIG-like Helicase Regulation of Chitinase 3-like 1 Axis and Pulmonary Metastasis Oncogenic activation of MAP kinase by BRAF pseudogene in thyroid tumors 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer Resistance to Raf inhibition in cancer.Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies.Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer.Thyroid cancer: current molecular perspectives.Molecular diagnostics of fine needle aspiration for the presurgical screening of thyroid nodules.Application of molecular diagnostics to the evaluation of the surgical approach to thyroid cancer alphaB-crystallin is mutant B-RAF regulated and contributes to cyclin D1 turnover in melanocytic cells.Cross-regulation between oncogenic BRAF(V600E) kinase and the MST1 pathway in papillary thyroid carcinoma New insights into the diagnosis of nodular goiter.Progression of BRAF-induced thyroid cancer is associated with epithelial-mesenchymal transition requiring concomitant MAP kinase and TGFβ signaling.Multi-targeted approach in the treatment of thyroid cancer.Prognostic factors of papillary and follicular carcinomas in Japan based on data of kuma hospital.Molecular and other novel advances in treatment of metastatic epithelial and medullary thyroid cancers BRAF V600E maintains proliferation, transformation, and tumorigenicity of BRAF-mutant papillary thyroid cancer cells Fine-needle aspiration of metastatic papillary thyroid carcinoma found in the liver.Change or die: targeting adaptive signaling to kinase inhibition in cancer cells.Molecular pathogenesis and mechanisms of thyroid cancer BRAF mutation may predict higher necessity of postoperative radioactive iodine ablation in papillary thyroid cancer High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma Low VHL mRNA expression is associated with more aggressive tumor features of papillary thyroid carcinoma.Utility of BRAF V600E mutation detection in cytologically indeterminate thyroid nodules Genetic mutations in the treatment of anaplastic thyroid cancer: a systematic review.Differentiated thyroid cancer: focus on emerging treatments for radioactive iodine-refractory patients.Complex regulation of the cyclin-dependent kinase inhibitor p27kip1 in thyroid cancer cells by the PI3K/AKT pathway: regulation of p27kip1 expression and localization Recurrent papillary thyroid carcinoma with pleural metastasis diagnosed by effusion cytology: a report of cases with clinicopathologic correlation.BRAF Mutations in Canine Cancers.BRAF gene: From human cancers to developmental syndromes.Occult oncocytic papillary thyroid carcinoma with lymphoid stroma (Warthin-like tumor): report of a case with concomitant mutations of BRAF V600E and V600K The Clinicopathological Features of BRAF Mutated Papillary Thyroid Cancers in Chinese Patients

P2860

Q24653496-3483F3B5-6FA6-4F0A-B5C9-1A20B6AECF4E Q24806439-DFAFAF6F-CADF-40B8-BAD0-420E1023EE5E Q26765947-AA895789-6425-4ECE-8AED-D5F2AAE222CA Q26853261-C9E9F158-CB11-41F2-AE06-DCE89AC2AC40 Q28076196-74C9FB06-B9C8-418C-B8A8-6CED7E7562A7 Q28244806-0045F28C-31B0-480C-B8E4-95AB93FB5D8E Q28253304-ED783584-8EAC-46A0-8C96-7F2BA43C12F2 Q28258450-C9069712-3C0D-41E3-BD76-073EBF0D9F3B Q28275702-43533ABE-018D-4115-9054-FD14CB73D04F Q28756117-7DAE6482-7539-4EF2-B654-ECF237F04FBB Q30367068-C8AACE01-F0C2-4C53-BDEB-9161D7598970 Q33651779-D26409BD-CD1F-4564-B2AC-38FBA3F78005 Q33691759-43C6AF71-E57E-455A-AA86-AC82251810A6 Q33707821-0AC7B68E-3201-4BB2-8D5A-888709A42095 Q33760910-FFAAD3AE-B81D-42E1-AB78-0A081817F009 Q33782114-B0BD1BE2-66F4-4A82-A1F4-E6B4F4C3B03D Q33782121-AD0F55EE-7453-4120-9A39-927E5ADC48EE Q33793960-DC27CD5B-75C3-4397-A643-FA0E65252843 Q33797782-5A90ADD8-5D2C-406A-B4A4-DD0520E1706B Q33827492-AD59CE58-1BED-4DFF-939F-5D52270610D8 Q33839230-C850348F-631B-4C73-8EE3-5DFB813287B8 Q33982413-58C4DB26-123A-49B8-88FB-2F99967401CE Q34041618-A0BC7DC1-0017-4E47-9439-047ED79DB1F2 Q34123724-D2CB4061-5B57-4D78-858D-D33A7ED2355D Q34123904-B4B00CDE-563E-4C62-9657-699F70881E8B Q34169547-25AE1457-171A-4E97-BE9F-AFC73A517D77 Q34225871-0BFD07D0-7E56-4769-AC30-FE5A1EE983CF Q34329018-58E5407F-6E3D-4C1C-90BD-DFBF5A27C0B8 Q34335766-6C86EDC9-DA36-4F59-BAD3-C210895A0389 Q34572289-354DA89E-4755-4954-A23C-7F100BCA250E Q34662980-ABE66E75-0897-4258-AF1C-96BF2A498446 Q34690607-40933C7D-945F-4B0B-A355-0D599FF9B9FE Q35051065-8A6596D9-C217-4B61-92C8-EA82416CFCAC Q35057314-E027F209-21E4-4153-9A2F-02164D4F0DB2 Q35083763-B09FEBAD-227B-4761-B35B-43F749D6A70A Q35114388-4547A318-9F49-45EA-A475-4C5D30A8BE2D Q35656395-358B18BA-239B-4075-A790-551231A189CB Q35802430-E2BE48CE-02D3-45D3-8024-9B30A08FFCC7 Q35854453-1E31ACF7-A4B3-4476-B9AC-A2017C000E0A Q35932262-14B6CBAC-6879-41AF-BA2E-E52CEA08F2E0

P2860

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

http://www.wikidata.org/entity/Q28206482

description

2003 nî lūn-bûn

@nan

2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@ast

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@en

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@nl

type

label

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@ast

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@en

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@nl

prefLabel

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@ast

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@en

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@nl

P1433

Q28206482-704F79DC-3F71-4138-982B-4769EF3CE618

P1476

Q28206482-734865B2-2E30-4C79-90E4-C23FA3A6CA7C

P2093

Q28206482-09D870ED-B152-4E5F-8748-1A37CCFF76F9

Q28206482-20421697-0C68-4D49-A341-151FC4EECDDB

Q28206482-2A8A2374-2CE0-4A12-8B06-06D53C6E5762

Q28206482-4461261F-5809-4530-8260-E5A35CC0C740

Q28206482-48233A79-1C4A-407F-95BF-95DF1F519AF3

Q28206482-9C0D39FC-BFC3-4E2A-80CB-3B1E216416A6

Q28206482-D1AD3FB2-CA1D-404E-AFC3-C999DAB9A87F

Q28206482-F1EE22AE-76F9-49F1-9D8D-14BCAB37E212

P304

Q28206482-4C7B4A19-8ED4-4382-B068-E11B9E436FCD

P31

Q28206482-D34390D2-D9F3-4FDB-AA00-A4E714D3F305

P3181

Q28206482-38AA08C9-6272-4B00-AABB-F723CF9C7DAC

P356

Q28206482-2FEA7B7B-CD81-469D-A8F5-6008B2330D88

P407

Q28206482-52FB563A-0438-4F96-A64A-B400DA12E05B

P433

Q28206482-9E46D9FB-CEF6-4A01-AD0B-A360842E5E0B

P478

Q28206482-196ABA96-7A5F-4AEE-8635-27E7113BD519

P50

Q28206482-6195FD1D-73A7-4030-A0E2-5AE3B011ECFB

Q28206482-94206539-2984-4BC0-AAE2-7F423E8C66EF

P577

Q28206482-5DEB303B-5DDE-4387-A1E6-3AF787D0B2A6

P5875

Q28206482-5E6B8FB7-A1D1-4767-AA65-74E0DD0268E8

P698

Q28206482-8F500A75-7231-4AA8-B86C-E6A221B57B1C

P3181

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

@en

P2093

Hiroyuki Namba

http://www.w3.org/2001/XMLSchema#string

Masahiro Nakashima

http://www.w3.org/2001/XMLSchema#string

Naomi Hayashida

http://www.w3.org/2001/XMLSchema#string

Shigeto Maeda

http://www.w3.org/2001/XMLSchema#string

Takashi Kanematsu

http://www.w3.org/2001/XMLSchema#string

Tatiana I Rogounovitch

http://www.w3.org/2001/XMLSchema#string

Tomayoshi Hayashi

http://www.w3.org/2001/XMLSchema#string

Vladimir A Saenko

http://www.w3.org/2001/XMLSchema#string

P304

4393-7

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1477742

http://www.w3.org/2001/XMLSchema#string

P356

10.1210/JC.2003-030305

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P50

Shunichi Yamashita

P577

2003-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5265642

http://www.w3.org/2001/XMLSchema#string

P698

12970315

http://www.w3.org/2001/XMLSchema#string